Keyphrases
Alpha-1 Antitrypsin
100%
Proteasome Inhibition
100%
Hematopoietic Stem Cell Transplantation
100%
Non-relapse Mortality
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
80%
Graft-versus-host Disease (GvHD)
60%
C-reactive Protein Level
40%
Tissue Injury
40%
Antiproteolytic Activity
40%
Enzymatic Activity
20%
Serum Samples
20%
Liver
20%
Immunomodulatory
20%
Trial Registration
20%
Improved Outcomes
20%
Serine Protease Inhibitor
20%
Antitrypsin
20%
Clinical Grade
20%
Immune Tolerance
20%
Human Epithelial Cells
20%
Augmentation Therapy
20%
Serine Protease
20%
Proteinase 3
20%
Steroid-refractory Graft-versus-host Disease
20%
AAT Deficiency
20%
C-reactive Protein
20%
Epithelial Cell Line
20%
Patient Serum
20%
Graves
20%
Leukocytes
20%
Disease-free
20%
Hematological Diseases
20%
Transplant Outcomes
20%
Ex Vivo Studies
20%
Functional Profile
20%
Marrow
20%
Radiochemotherapy
20%
Acute Phase Reactants
20%
Circulating Leukocytes
20%
Gap Closure Assay
20%
Gap Closure
20%
Antiproteolytic
20%
Medicine and Dentistry
Alpha 1 Antitrypsin
100%
Proteinase Inhibition
100%
Hematopoietic Stem Cell Transplantation
100%
Graft Versus Host Reaction
80%
Allogeneic Hematopoietic Stem Cell Transplantation
80%
C Reactive Protein
60%
Ex Vivo
40%
Tissue Injury
40%
Leukocyte
40%
Protein Degradation
40%
Enzyme Activity
20%
Conditioning
20%
Trypsin Inhibitor
20%
Serine Proteinase Inhibitor
20%
Immunological Tolerance
20%
Myeloblastin
20%
Serine Proteinase
20%
Acute Phase Protein
20%
Epithelial Cell Line
20%
Chemoradiotherapy
20%
Sulfhemoglobinemia
20%
Biochemistry, Genetics and Molecular Biology
Alpha 1-Antitrypsin
100%
Proteinase Inhibition
100%
Hematopoietic Stem Cell Transplantation
100%
Host
80%
Allogeneic Hematopoietic Stem Cell Transplantation
80%
C-Reactive Protein
60%
Protein Catabolism
40%
Leukocyte
40%
Enzyme Activity
20%
Genetics
20%
Conditioning
20%
Serine Protease
20%
Serine Protease Inhibitor
20%
Acute Phase Protein
20%
Immunological Tolerance
20%
Myeloblastin
20%
Proteinase 3
20%
Immunology and Microbiology
Alpha 1-Antitrypsin
100%
Proteinase Inhibition
100%
Hematopoietic Stem Cell Transplantation
100%
Graft-Versus-Host Disease
80%
Allogeneic Hematopoietic Stem Cell Transplantation
80%
C-Reactive Protein
60%
Leukocyte
40%
Protein Degradation
40%
Enzyme Activity
20%
Conditioning
20%
Immune Tolerance
20%
Acute Phase Protein
20%
Epithelial Cell Line
20%
Pharmacology, Toxicology and Pharmaceutical Science
Proteinase
100%
Alpha 1 Antitrypsin
100%
Graft Versus Host Reaction
100%
C Reactive Protein
75%
Tissue Injury
50%
Serine Proteinase Inhibitor
25%
Serine Proteinase
25%
Myeloblastin
25%
Trypsin Inhibitor
25%
Acute Phase Protein
25%
Chemotherapy
25%
Hematologic Disease
25%